3B Pharmaceuticals

A graphic of two people standing atop coins shaking hands
Biotech

Novartis pays out $40M cash in another radiopharmaceutical deal

Novartis is offering up to $425M in biobucks for exclusive licensing rights to 3B Pharmaceuticals’ FAP-targeting peptide tech.
Gabrielle Masson Apr 24, 2023 1:53pm
Clovis Oncology

Clovis strikes 3B deal to move into radiopharmaceuticals

Sep 23, 2019 8:35am